Johnson & Johnson is Investing Billions in Clinical Care Solutions

In a similarly related stride, it was announced late last week that J&J has completed its acquisition of Abiomed, a leading biomedical devices company that primarily focuses on cardiac support devices. Ashley McEvoy, Executive Vice President and Worldwide Chairman of MedTech at Johnson & Johnson, explained the vision behind the acquisition: “The completion of this acquisition allows Johnson & Johnson MedTech to expand our portfolio in the high growth cardiovascular markets, adding solutions for heart recovery to our global market leading Biosense Webster electrophysiology business.